A AVANOS MED INC
| Market Cap | $608.50M |
| P/E Ratio | — |
| Forward P/E | 10.47 |
| Dividend Yield | — |
| Beta | 1.09 |
| 52W Range | $9.30 - $15.68 |
| # Hedge Funds | 0 |
| Sector | Healthcare |
| Industry | Medical Devices |
Hedge Fund Ownership
| Investor 0 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|
Insider Trading
| Insider Name of the company insider who made the trade 8 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Holbrook KerrSVP, Chief Commercial Officer | Sale | 761 | $11.01 | $8.38K | 18 Nov 2025 | 19 Nov 2025 |
| Holbrook KerrSVP, Chief Commercial Officer | Sale | 100 | $11.01 | $1.10K | 18 Nov 2025 | 19 Nov 2025 |
| Holbrook KerrSVP, Chief Commercial Officer | Sale | 13,834 | $11.00 | $152.17K | 18 Nov 2025 | 19 Nov 2025 |
| Holbrook KerrSVP, Chief Commercial Officer | Sale | 305 | $11.02 | $3.36K | 18 Nov 2025 | 19 Nov 2025 |
| Kerr HolbrookSVP, Chief Commercial Officer | Sale | 761 | $11.01 | $8.38K | 18 Nov 2025 | 19 Nov 2025 |
| Kerr HolbrookSVP, Chief Commercial Officer | Sale | 13,834 | $11.00 | $152.17K | 18 Nov 2025 | 19 Nov 2025 |
| Kerr HolbrookSVP, Chief Commercial Officer | Sale | 305 | $11.02 | $3.36K | 18 Nov 2025 | 19 Nov 2025 |
| Kerr HolbrookSVP, Chief Commercial Officer | Sale | 100 | $11.01 | $1.10K | 18 Nov 2025 | 19 Nov 2025 |
Frequently Asked Questions
What is AVNS stock price today?
AVANOS MED INC (AVNS) is currently trading at $13.09. The stock has a 52-week range of $9.30 to $15.68 and a market capitalization of $608.50M.
Is AVNS a good stock to buy in 2026?
AVANOS MED INC has a P/E ratio of N/A (forward P/E: 10.5), a dividend yield of none, and 1-year performance of -12.5%. 0 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling AVNS stock?
There have been 8 insider transactions for AVNS in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has AVNS stock performed over the past year?
AVANOS MED INC (AVNS) has returned -12.5% over the past 12 months. The stock traded between $9.30 and $15.68 during this period, and is currently at $13.09.
Which hedge funds own AVNS (AVANOS MED INC)?
0 tracked hedge funds currently hold AVNS in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is AVNS's market cap and valuation?
AVANOS MED INC (AVNS) has a market capitalization of $608.50M. The trailing P/E ratio is N/A and forward P/E is 10.5. The stock is classified in the Healthcare sector.
What is AVNS's revenue and profitability?
AVANOS MED INC reported revenue of $701.20M with net income of N/A and a profit margin of N/A. The stock has a beta of 1.09.
What sector is AVNS in and who are its biggest institutional holders?
AVANOS MED INC (AVNS) operates in the Healthcare sector. It is held by 0 tracked hedge funds. See the ownership table above for the complete list.